CD44 and breast carcinoma: TNBC forms the largest part of the basal-like subtype (~80%) [6,14], which is the most aggressive molecular subtype with the highest content of breast cancer stem cells (BSCSs) characterized by the most common BCSC biomarkers, CD44+/CD24−/low and ALDH1+ [15,16,17,18].